Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Am J Psychiatry. 2012 May;169(5):465-75. doi: 10.1176/appi.ajp.2012.11081302.
Premenstrual dysphoric disorder, which affects 2%–5% of premenopausal women, was included in Appendix B of DSMIV, "Criterion Sets and Axes Provided for Further Study." Since then, aided by the inclusion of specific and rigorous criteria in DSM-IV, there has been an explosion of research on the epidemiology, phenomenology, pathogenesis, and treatment of the disorder. In 2009, the Mood Disorders Work Group for DSM-5 convened a group of experts to examine the literature on premenstrual dysphoric disorder and provide recommendations regarding the appropriate criteria and placement for the disorder in DSM-5. Based on thorough review and lengthy discussion, the work group proposed that the information on the diagnosis, treatment, and validation of the disorder has matured sufficiently for it to qualify as a full category in DSM-5. A move to the position of category, rather than a criterion set in need of further study, will provide greater legitimacy for the disorder and encourage the growth of evidence-based research, ultimately leading to new treatments.
经前期烦躁障碍影响了 2%-5%的绝经前女性，被列入 DSM-IV 附录 B“标准集和供进一步研究的轴”。从那时起，由于在 DSM-IV 中纳入了具体和严格的标准，对该障碍的流行病学、现象学、发病机制和治疗的研究迅速增加。2009 年，DSM-5 情绪障碍工作组召集了一组专家，审查了经前期烦躁障碍的文献，并就该障碍在 DSM-5 中的适当标准和位置提出了建议。基于全面的审查和长时间的讨论，工作组提出，关于该障碍的诊断、治疗和验证的信息已经足够成熟，可以将其作为 DSM-5 中的一个完整类别。从标准集移到类别位置，而不是需要进一步研究的标准集，将为该障碍提供更大的合法性，并鼓励基于证据的研究的发展，最终带来新的治疗方法。
